Three Planned Studies of an Experimental Drug to Treat Rare Epilepsies Have Been Announced
The organisations Takeda Pharmaceutical Company and Ovid Therapeutics are collaborating over the development of the experimental drug TAK-935/OV935 as a possible treatment for several rare epilepsy syndromes. Takeda has just…